1 Min Read
July 7 (Reuters) - Compumedics Ltd:
* Unaudited group FY17 EBITDA is expected to be between $2.1 million and $3.6 million before $1.6 million of one- off restructuring costs
* Restructuring activities in core capital equipment business resulted in lower than expected sales for twelve months to 30 June 2017 of about $33 mln
* "Expects us business to contribute strongly to overall group performance in FY18"
* "Company expects to remain cash flow positive" Source text for Eikon: Further company coverage: